Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis
Nicolai Haase, Jørn Wetterslev(Copenhagen University Hospital), Anders Perner(Unknown), Mik Wetterslev(Copenhagen University Hospital), Louise Inkeri Hennings(Copenhagen University Hospital), Martin Siegemund(Aalborg University), Bo Kobberø Lauridsen(Copenhagen University Hospital)
Cited by 309
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Hydroxyethyl Starch 130/0.42 versus Ringer's Acetate in Severe Sepsis
|New England Journal of Medicine|2012|1.8k